Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Interim Analysis of a Phase II Study of the GCLLSG and fcgcll/MW

作者:Stilgenbauer Stephan; Cymbalista Florence; Leblond Veronique; Delmer Alain; Winkler Dirk; Buehler Andreas; Zenz Thorsten; Mack Silja; Busch Raymonde; Hinke Axel; Choquet Sylvain; Dartigeas Caroline; Cazin Bruno; Tournilhac Olivier; Rieger Michael; Alt Juergen; Soekler Martin; Schetelig Johannes; Dreger Peter; Hallek Michael; Doehner Hartmut
来源:53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), 2011-12-10 to 2011-12-13.